Stay updated on Pediatric CheckMate Clinical Trial
Sign up to get notified when there's something new on the Pediatric CheckMate Clinical Trial page.

Latest updates to the Pediatric CheckMate Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record for nivolumab with or without ipilimumab in younger patients with recurrent or refractory solid tumors is now displayed instead of an access-denied page. It includes the study design, eligibility details, participating locations, outcome measures, and supporting documents.SummaryDifference89%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition. The page body still displays a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page body now displays a 403 Forbidden message and a Home link instead of study-record content.SummaryDifference0.5%

Stay in the know with updates to Pediatric CheckMate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric CheckMate Clinical Trial page.